Cytiva announced on Jan. 16, 2025 that it has teamed up with Cellular Origins, a TTP company based in the UK that specializes in advancing scalable and cost-effective cell and gene therapy (CGT) manufacturing, to combine technology platforms that will offer automated, robotic manufacturing of CGTs. Through the collaboration, Cytiva’s automated Sefia platform will be combined with Cellular Origin’s Constellation, an automated robotic platform. Source: Biopharm International 21/1/2025